Detection of Multiple Disease Indicators by an Autonomous Biomolecular Computer
Authors:
- 14 June 2011
- journal article
- letter
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 11 (7) , 2989-2996
Abstract
The promise of biomolecular computers is their ability to interact with naturally occurring biomolecules, enabling in the future the development of context-dependent programmable drugs. Here we show a context-sensing mechanism of a biomolecular automaton that can simultaneously sense different types of molecules, allowing future integration of biomedical knowledge on a broad range of molecular disease symptoms in the decision of a biomolecular computer to release a drug molecule.Keywords
This publication has 56 references indexed in Scilit:
- Reprogramming Cellular Behavior with RNA Controllers Responsive to Endogenous ProteinsScience, 2010
- RETRACTED: Selective cell death mediated by small conditional RNAsProceedings of the National Academy of Sciences, 2010
- Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to ApplicationsNano Letters, 2010
- Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systemsProceedings of the National Academy of Sciences, 2010
- Logic integration of mRNA signals by an RNAi-based molecular computerNucleic Acids Research, 2010
- Robustness and modularity properties of a non-covalent DNA catalytic reactionNucleic Acids Research, 2010
- Biocomputers: from test tubes to live cellsMolecular BioSystems, 2009
- Model‐guided design of ligand‐regulated RNAi for programmable control of gene expressionMolecular Systems Biology, 2008
- MicroRNA expression profiles classify human cancersNature, 2005
- An autonomous molecular computer for logical control of gene expressionNature, 2004